Literature DB >> 29191570

The effect of interactions between genetics and cannabis use on neurocognition. A review.

E Cosker1, T Schwitzer2, N Ramoz3, F Ligier4, L Lalanne5, P Gorwood6, R Schwan7, V Laprévote8.   

Abstract

BACKGROUND: Cannabis is one of the most widely-used drugs in industrialized countries. It is now well established that cannabis use impacts neurocognition. In the intoxication period time episodic memory, working memory and attention are impacted and impulsivity is increased. The long-term effects of cannabis use tend to be similar. Various internal factors, such as sex differences, modulate this impact. It is unclear whether genetic variations can also influence the impact of cannabis on neurocognition. We set out to examine the impact of genetic variations on neurocognition in cannabis users.
METHOD: We conducted a search via the PubMed, Web of Science, and ScienceDirect databases to identify studies measuring neurocognition and assessing genotypes in the context of cannabis use.
RESULTS: We included 13 articles. We found that working memory, verbal and visual memory and sustained attention are more impacted during intoxication in subjects with the Val COMT allele. COMT gene could also modulate sustained attention in regular use. The CNR1, AKT1, DBH and 5-HTT/SLC6A4 genes may also modulate effects.
CONCLUSION: Most of these genes are linked to schizophrenia. A fuller understanding of their impact on the effects of cannabis on neurocognition would thus help elucidate the mechanisms linking cannabis and psychosis. However, evidence is still scant, and more research is needed.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  AKT1; CNR1; COMT; Cannabis; Cognition

Mesh:

Year:  2017        PMID: 29191570     DOI: 10.1016/j.pnpbp.2017.11.024

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

Review 1.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

Review 2.  Adverse Effects of Recreational and Medical Cannabis.

Authors:  Ivan Urits; Karina Charipova; Kyle Gress; Nathan Li; Amnon A Berger; Elyse M Cornett; Hisham Kassem; Anh L Ngo; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2021-01-12

3.  Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies.

Authors:  M Taylor; J Cousijn; F Filbey
Journal:  Curr Addict Rep       Date:  2019-10-24

Review 4.  Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.

Authors:  Zeinab Breijyeh; Buthaina Jubeh; Sabino A Bufo; Rafik Karaman; Laura Scrano
Journal:  Toxins (Basel)       Date:  2021-02-05       Impact factor: 4.546

5.  Association studies of dopamine synthesis and metabolism genes with multiple phenotypes of heroin dependence.

Authors:  Yunxiao Li; Yongsheng Zhu; Jianghua Lai; Xugang Shi; Yuanyuan Chen; Jinyu Zhang; Shuguang Wei
Journal:  BMC Med Genet       Date:  2020-07-31       Impact factor: 2.103

6.  Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial.

Authors:  Tory R Spindle; Edward J Cone; Nicolas J Schlienz; John M Mitchell; George E Bigelow; Ronald Flegel; Eugene Hayes; Ryan Vandrey
Journal:  JAMA Netw Open       Date:  2018-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.